Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer Meeting Abstract

  

Authors:	Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; Shen, R.; Robson, M. E.; Chandarlapaty, S.; Reis-Filho, J. S.; Razavi, P.
Abstract Title:	Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
Meeting Title:	2022 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	16 Suppl.
Meeting Dates:	2022 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-06-01
Language:	English
ACCESSION:	WOS:000863680300067
PROVIDER:	wos
DOI:	10.1200/JCO.2022.40.16_suppl.1010
Notes:	Meeting Abstract: 1010 -- Meeting also held virtually -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201546